• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中的肠道屏障功能障碍:发病机制和治疗基础。

Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics.

机构信息

Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First St. S.W., Rochester, MN, 55905, USA.

Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Mayo Clinic, Rochester, MN, USA.

出版信息

Dig Dis Sci. 2023 Dec;68(12):4306-4320. doi: 10.1007/s10620-023-08122-w. Epub 2023 Sep 29.

DOI:10.1007/s10620-023-08122-w
PMID:37773554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10798146/
Abstract

The intestinal barrier is composed of several essential elements including luminal enzymes, bile acids, water layer, epithelial layer, and enterocyte layer. It acts as a dynamic interface between the luminal contents of food, commensal and pathogenic bacteria, and the gastrointestinal tract. The role of barrier dysfunction is of significant research interest in the development and targeted treatment of chronic inflammatory gastrointestinal conditions, such as inflammatory bowel disease. This review aims to examine the role of intestinal barrier dysfunction in the development of inflammatory bowel disease, the pathophysiology of increased barrier permeability in inflammatory bowel disease, and to explore potential treatment targets and clinical applications.

摘要

肠道屏障由几个重要的元素组成,包括腔内酶、胆汁酸、水层、上皮层和肠细胞层。它作为食物、共生菌和致病菌与胃肠道之间的腔内内容物的动态界面。屏障功能障碍的作用在慢性炎症性胃肠道疾病(如炎症性肠病)的发展和靶向治疗中具有重要的研究意义。本综述旨在探讨肠道屏障功能障碍在炎症性肠病发展中的作用、炎症性肠病中屏障通透性增加的病理生理学,以及探索潜在的治疗靶点和临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd0c/10798146/470b8aaee02a/nihms-1959332-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd0c/10798146/c0f9fcee762b/nihms-1959332-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd0c/10798146/470b8aaee02a/nihms-1959332-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd0c/10798146/c0f9fcee762b/nihms-1959332-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd0c/10798146/470b8aaee02a/nihms-1959332-f0002.jpg

相似文献

1
Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics.炎症性肠病中的肠道屏障功能障碍:发病机制和治疗基础。
Dig Dis Sci. 2023 Dec;68(12):4306-4320. doi: 10.1007/s10620-023-08122-w. Epub 2023 Sep 29.
2
Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions.修复 IBD 中的破损屏障:肠通透性、肠上皮细胞和细胞连接。
Curr Drug Targets. 2013 Nov;14(12):1460-70. doi: 10.2174/1389450111314120011.
3
Intestinal barrier function in health and gastrointestinal disease.肠道屏障功能在健康和胃肠道疾病中的作用。
Neurogastroenterol Motil. 2012 Jun;24(6):503-12. doi: 10.1111/j.1365-2982.2012.01921.x.
4
Negative Effects of a High-Fat Diet on Intestinal Permeability: A Review.高脂肪饮食对肠道通透性的负面影响:综述。
Adv Nutr. 2020 Jan 1;11(1):77-91. doi: 10.1093/advances/nmz061.
5
Layered defense: how mucus and tight junctions seal the intestinal barrier.分层防御:黏液和紧密连接如何密封肠道屏障。
J Mol Med (Berl). 2017 Sep;95(9):927-934. doi: 10.1007/s00109-017-1557-x. Epub 2017 Jul 13.
6
A Novel Role of SLC26A3 in the Maintenance of Intestinal Epithelial Barrier Integrity.SLC26A3 在维持肠道上皮屏障完整性中的新作用。
Gastroenterology. 2021 Mar;160(4):1240-1255.e3. doi: 10.1053/j.gastro.2020.11.008. Epub 2020 Nov 13.
7
Wall of Resilience: How the Intestinal Epithelium Prevents Inflammatory Onslaught in the Gut.韧性之壁:肠道上皮如何预防肠道炎症侵袭
Cell Mol Gastroenterol Hepatol. 2025;19(2):101423. doi: 10.1016/j.jcmgh.2024.101423. Epub 2024 Oct 24.
8
Cytoskeletal Organization and Cell Polarity in the Pathogenesis of Crohn's Disease.细胞骨架组织和细胞极性在克罗恩病发病机制中的作用。
Clin Rev Allergy Immunol. 2021 Apr;60(2):164-174. doi: 10.1007/s12016-020-08795-5.
9
Regulation of intestinal permeability: The role of proteases.肠道通透性的调节:蛋白酶的作用。
World J Gastroenterol. 2017 Mar 28;23(12):2106-2123. doi: 10.3748/wjg.v23.i12.2106.
10
Galacto-oligosaccharides Protect the Intestinal Barrier by Maintaining the Tight Junction Network and Modulating the Inflammatory Responses after a Challenge with the Mycotoxin Deoxynivalenol in Human Caco-2 Cell Monolayers and B6C3F1 Mice.低聚半乳糖通过维持紧密连接网络和调节人源Caco-2细胞单层及B6C3F1小鼠在受到霉菌毒素脱氧雪腐镰刀菌烯醇攻击后的炎症反应来保护肠道屏障。
J Nutr. 2015 Jul;145(7):1604-13. doi: 10.3945/jn.114.209486. Epub 2015 May 27.

引用本文的文献

1
Xianglian Anchang Decoction Mitigates Ulcerative Colitis via Inhibition of TLR-4-Mediated Pyroptosis.香连安肠汤通过抑制TLR-4介导的细胞焦亡减轻溃疡性结肠炎
J Inflamm Res. 2025 Sep 4;18:12245-12261. doi: 10.2147/JIR.S533936. eCollection 2025.
2
Role of ETS2 gene in inflammatory bowel disease: A narrative review.ETS2基因在炎症性肠病中的作用:一篇叙述性综述。
Medicine (Baltimore). 2025 Sep 5;104(36):e44234. doi: 10.1097/MD.0000000000044234.
3
Influence of Microplastics on Manifestations of Experimental Chronic Colitis.微塑料对实验性慢性结肠炎表现的影响

本文引用的文献

1
Intestinal Barrier Healing Is Superior to Endoscopic and Histologic Remission for Predicting Major Adverse Outcomes in Inflammatory Bowel Disease: The Prospective ERIca Trial.在预测炎症性肠病的主要不良结局方面,肠道屏障愈合优于内镜和组织学缓解:前瞻性ERIca试验
Gastroenterology. 2023 Feb;164(2):241-255. doi: 10.1053/j.gastro.2022.10.014. Epub 2022 Oct 21.
2
Interleukin-22 Ameliorates Dextran Sulfate Sodium-Induced Colitis through the Upregulation of lncRNA-UCL to Accelerate Claudin-1 Expression via Sequestering miR-568 in Mice.白细胞介素-22 通过上调 lncRNA-UCL 加速 Claudin-1 表达来减轻葡聚糖硫酸钠诱导的结肠炎小鼠模型的炎症反应。
Oxid Med Cell Longev. 2022 Aug 31;2022:8543720. doi: 10.1155/2022/8543720. eCollection 2022.
3
Toxics. 2025 Aug 21;13(8):701. doi: 10.3390/toxics13080701.
4
Lumefantrine ameliorates DSS-induced colitis by targeting FLI-1 to suppress NF-κB signaling.卤泛群通过靶向FLI-1抑制NF-κB信号通路来改善右旋糖酐硫酸酯钠诱导的结肠炎。
Front Pharmacol. 2025 Jul 11;16:1614978. doi: 10.3389/fphar.2025.1614978. eCollection 2025.
5
The Role of Akkermansia muciniphila in Disease Regulation.嗜黏蛋白阿克曼氏菌在疾病调节中的作用。
Probiotics Antimicrob Proteins. 2025 Jul 9. doi: 10.1007/s12602-025-10642-y.
6
Intact glycoconjugates from Taenia crassiceps excreted/secreted products ameliorate chemically induced colitis by modulating inflammation and strengthening adherens junctions.来自肥胖带绦虫排泄/分泌产物的完整糖缀合物通过调节炎症和加强黏附连接来改善化学诱导的结肠炎。
Inflammopharmacology. 2025 Jun 27. doi: 10.1007/s10787-025-01821-y.
7
Yeast microcapsules encapsulating metal-phenolic nanozymes alleviate ulcerative colitis by mitigating oxidative stress and modulating the gut microbiota.包裹金属酚类纳米酶的酵母微胶囊通过减轻氧化应激和调节肠道微生物群来缓解溃疡性结肠炎。
Mater Today Bio. 2025 May 23;32:101902. doi: 10.1016/j.mtbio.2025.101902. eCollection 2025 Jun.
8
Podophyllotoxin Alleviates DSS-Induced Ulcerative Colitis via PI3K/AKT Pathway Activation.鬼臼毒素通过激活PI3K/AKT信号通路减轻右旋糖酐硫酸钠诱导的溃疡性结肠炎
Physiol Res. 2025 Apr 30;74(2):287-300.
9
Optimal Approaches to Treating and Preventing Acute and Chronic Pouchitis by Altering Microbial Profiles.通过改变微生物谱治疗和预防急慢性袋炎的最佳方法。
Gastroenterol Clin North Am. 2025 Jun;54(2):469-483. doi: 10.1016/j.gtc.2024.12.007. Epub 2025 Jan 9.
10
Long non-coding RNA ANRIL/p65 negative feedback loop protects intestinal barrier function in inflammatory bowel disease.长链非编码RNA ANRIL/p65负反馈环在炎症性肠病中保护肠道屏障功能。
Noncoding RNA Res. 2025 Mar 14;12:167-179. doi: 10.1016/j.ncrna.2025.03.002. eCollection 2025 Jun.
Finding a mate for MLCK: improving the potential for therapeutic targeting of gut permeability.为肌球蛋白轻链激酶寻找配对物:提高肠道通透性治疗靶点的潜力
Gut. 2022 Jul 18. doi: 10.1136/gutjnl-2022-327599.
4
Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.改变的肠道微生物群落组成和功能与克罗恩病患者健康亲属的肠道屏障功能障碍有关。
Gastroenterology. 2022 Nov;163(5):1364-1376.e10. doi: 10.1053/j.gastro.2022.07.004. Epub 2022 Jul 16.
5
Tacrolimus-binding protein FKBP8 directs myosin light chain kinase-dependent barrier regulation and is a potential therapeutic target in Crohn's disease.他克莫司结合蛋白 FKBP8 指导肌球蛋白轻链激酶依赖性屏障调节,是克罗恩病的潜在治疗靶点。
Gut. 2023 May;72(5):870-881. doi: 10.1136/gutjnl-2021-326534. Epub 2022 May 10.
6
Rhamnose Is Superior to Mannitol as a Monosaccharide in the Dual Sugar Absorption Test: A Prospective Randomized Study in Children With Treatment-Naïve Celiac Disease.在双糖吸收试验中,鼠李糖作为单糖优于甘露醇:一项针对初治乳糜泻儿童的前瞻性随机研究。
Front Pediatr. 2022 Apr 7;10:874116. doi: 10.3389/fped.2022.874116. eCollection 2022.
7
Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease.肠道微生物代谢物介导的炎症性肠病发病机制中的肠道屏障调节。
Nutrients. 2021 Nov 26;13(12):4259. doi: 10.3390/nu13124259.
8
Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease.靶向 uPA-uPAR 相互作用改善炎症性肠病的肠道上皮屏障完整性。
EBioMedicine. 2022 Jan;75:103758. doi: 10.1016/j.ebiom.2021.103758. Epub 2021 Dec 18.
9
Present and Future Therapeutic Approaches to Barrier Dysfunction.屏障功能障碍的当前及未来治疗方法
Front Nutr. 2021 Oct 28;8:718093. doi: 10.3389/fnut.2021.718093. eCollection 2021.
10
PTPN2 mutations cause epithelium-intrinsic barrier loss that synergizes with mucosal immune hyperactivation.PTPN2 突变导致上皮固有屏障丧失,与黏膜免疫过度激活协同作用。
J Clin Invest. 2021 Sep 1;131(17). doi: 10.1172/JCI151414.